Showing results (41-50 of 122) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusionM L Slevin, E M Piall, G W Aherne, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphomaA Rohatiner, M L Slevin, H S Dhaliwal, et al.Journal of Immunological Methods|August 30, 1992
Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditionsP W Thavasu, S Longhurst, S P Joel, et al.Clinical Chemistry|December 1, 1976
How accurate are lactate dehydrogenase isoenzyme estimations by the thin-layer agarose fluorescent technique?D McKenzie, P I Clark, A R HendersonCancer Chemotherapy and Pharmacology|January 1, 1986
The effect of dose on the bioavailability of oral etoposideV J Harvey, M L Slevin, S P Joel, et al.British Journal of Cancer|July 17, 1998
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancerP D Peppercorn, R H Reznek, P Wilson, et al.Cancer|September 15, 1984
Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycinV J Harvey, M L Slevin, B A Ponder, et al.British Journal of Cancer|November 1, 1988
The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapyB Ward, S Mather, J Shepherd, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancerM T Seymour, J T Dent, D Papamichael, et al.European Journal of Cancer Care|March 1, 1996
The experience and impact of contacting a cancer information serviceM J Venn, E Darling, C Dickens, et al.Pageof 13